Skip to Content

Thermo Fisher seeks to buy pharma services company PPD for $15 billion: report

Thermo Fisher Scientific Inc. (TMO) is approaching a deal to buy pharmaceutical-testing company PPD Inc. (PPD) for more than $15 billion, the Wall Street Journal reported (link) Wednesday, citing people familiar with the deal, which could be formalized as soon as this week. Wilmington, N.C.-based PPD, with a market cap around $13.6 billion, is a contract-research company, running drug trials for pharma companies as well as provinding lab services. Thermo Fisher, based in Waltham, Mass., sells lab equipment, chemicals and tests, among other life-sciences services and products, the Journal said. Thermo Fisher has a market cap around $188 billion. PPD shares rose 2% in the extended session after ending the regular trading day up 12%; Thermo Fisher shares were up 1.5% after closing down 1.4%.

-Claudia Assis; 415-439-6400;


(END) Dow Jones Newswires

04-14-21 1739ET

Copyright (c) 2021 Dow Jones & Company, Inc.